There is research on this stock available only to PRO subscribers.
From other sites
at Benzinga.com (Dec 18, 2014)
at MarketWatch.com (Dec 17, 2010)
There are no Transcripts on NYMX.
We currently have no Breaking News on this stock.
NYMX vs. ETF Alternatives
Nymox Pharmaceutical Corp along with its subsidiaries is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Other News & PR